Consensus Stryker Corporation Toronto S.E.

Stocks

SYK

CA8636701051

Medical Equipment, Supplies & Distribution

Delayed Toronto S.E. 05:00:31 22/10/26 am AEDT			5-day change	1st Jan Change
20.04 ^CAD	-2.48%		+5.36%	-

15/10	Stryker Launches Sonopet 3, Delivering Greater Power And Precision In Ultrasonic Tissue Removal	CI
15/10	Stryker Receives FDA Clearance for Ultrasonic Tissue Removal Platform	MT

e3.4RTcorHz2rnTHCQc5nKmHSWn-k-T2tGfpSI3C3yz7Qs.g2Kf0cTDjMyKdHEkjyrRUXD_kAeijOX-7lR7YEnColmqWYaa4aSw9ZRqaQ~a9fdaa73f6eec72e52fdea16bd65cc58

Analysts' recommendations: Stryker Corporation

12/10	BTIG Adjusts Price Target on Stryker to $316 From $358	MT
10/10	Leerink Partners Adjusts Stryker Price Target to $353 From $403	MT
07/10	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
07/10	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
07/10	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
30/09	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
22/09	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
22/09	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
21/09	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
18/09	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
18/09	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
14/09	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09/09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09/09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09/09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
18/08	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
13/08	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
06/08	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
04/08	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
03/08	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
31/07	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
31/07	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
31/07	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
31/07	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
31/07	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
STRYKER CORPORATION	-	-	-	-
ABBOTT LABORATORIES				+17.83%
STRYKER CORPORATION				+19.12%
MEDTRONIC PLC				+10.55%
ESSILORLUXOTTICA				+46.58%
CENCORA, INC.				+7.11%
HOYA CORPORATION				+17.83%
BECTON, DICKINSON AND COMPANY				+0.14%
IDEXX LABORATORIES, INC.				+25.11%
DEXCOM, INC.				+12.5%
Average				+17.42%
Weighted average by Cap.				+17.90%